We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ELTP Elite Pharmaceuticals Inc (QB)

-0.0145 (-8.92%)
Feb 23 2024 - Closed
Delayed by 15 minutes

Elite Pharmaceuticals (QB) Financial Summary

The current ELTP market cap is 150.06M. The company's latest EPS is USD 0.0035 and P/E is 42.86.

Year End March 30 2023 20192020202120222023
Total Revenue 7.57M18M25.38M32.26M34.16M
Operating Income -9.16M-2.29M2.1M5.07M3.68M
Net Income -9.28M-2.24M5.09M8.9M3.56M
Year End March 30 2023 20192020202120222023
Total Assets 24.4M24.96M26.19M35.15M40.9M
Total Liabilities 13.01M14.3M10.04M9.93M11.94M
Total Equity -2.51M10.66M16.15M25.22M28.96M

Cash Flow

Year End March 30 2023 20192020202120222023
Operating -6.79M-1.79M3.19M6.51M3.34M
Investing 331k-35k-263k-499k-5.74M
Financing 1.57M690k-870k-667k1.7M
Market Cap 150.06M
Price to Earnings Ratio 42.86
Price to Sales Ratio 4.45
Price to Cash Ratio 19.48
Price to Book Ratio 5.25
Dividend Yield -

Share Statistics

Shares Outstanding 1.01B
Average Volume (1 week) 2.19M
Average Volume (1 Month) 1.58M
52 Week Change 347.13%
52 Week High 0.2119
52 Week Low 0.028
Spread (Intraday) 0.01 (5.63%)

Company Info

Company Name Elite Pharmaceuticals Inc (QB)
Address 321 w. winnie lane
carson city, nevada 89703
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |